Xiaodong Xue

1.8k total citations
46 papers, 1.4k citations indexed

About

Xiaodong Xue is a scholar working on Surgery, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaodong Xue has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Molecular Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaodong Xue's work include Cardiac Ischemia and Reperfusion (8 papers), Sirtuins and Resveratrol in Medicine (7 papers) and Wound Healing and Treatments (5 papers). Xiaodong Xue is often cited by papers focused on Cardiac Ischemia and Reperfusion (8 papers), Sirtuins and Resveratrol in Medicine (7 papers) and Wound Healing and Treatments (5 papers). Xiaodong Xue collaborates with scholars based in China, Australia and Hong Kong. Xiaodong Xue's co-authors include Huishan Wang, Liming Yu, Yang Yang, Yinli Xu, Zhi Li, Xue Dong, Jian Zhang, Jian Zhang, Jinsong Han and Zhonglu Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaodong Xue

42 papers receiving 1.3k citations

Peers

Xiaodong Xue
Comparison fields: 5 of 97
  • Molecular Biology 627
  • Cardiology and Cardiovascular Medicine 310
  • Physiology 230
  • Pathology and Forensic Medicine 180
  • Epidemiology 162
Replace Buying Li with:
Buying Li China
Mengen Zhai China
Haifeng Pei China
Reza Badalzadeh Iran
Yinli Xu China
Mingge Ding China
Feng Fu China
Jianjun Lv China
Buying Li China View profile →
Citations per field, relative to Xiaodong Xue
Xiaodong Xue · 1×
Citations per year, relative to Xiaodong Xue
Xiaodong Xue · 1×

Countries citing papers authored by Xiaodong Xue

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Xue more than expected).

Fields of papers citing papers by Xiaodong Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Xue. The network helps show where Xiaodong Xue may publish in the future.

Co-authorship network of co-authors of Xiaodong Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Xue. A scholar is included among the top collaborators of Xiaodong Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Xue. Xiaodong Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 9
3 6
4 5
5 23
6 3
7 11
8 0
9 25
10 47
11 0
12 22
13 103
14 184
15 23
16 1
17 5
18 14
19 36
20 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026